Log in
Enquire now
‌

US Patent 11987815 Methods for reprogramming somatic cells

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119878150
Patent Inventor Names
Konrad Hochedlinger0
Rudolf Jaenisch0
Date of Patent
May 21, 2024
0
Patent Application Number
166658210
Date Filed
October 28, 2019
0
Patent Citations
‌
US Patent 11655459 Methods for reprogramming somatic cells
0
‌
US Patent 10093904 Reprogramming of somatic cells
0
‌
US Patent 10457917 Methods for reprogramming somatic cells
0
‌
US Patent 7015037 Multiponent adult stem cells and methods for isolation
0
‌
US Patent 7524677 Mammalian cultured inner cell mass cell culture using a g1 cell as nuclear donor
0
‌
US Patent 7601699 Production of reprogrammed cells with restored potential
0
‌
US Patent 7682828 Methods for reprogramming somatic cells
0
‌
US Patent 7687266 Pluripotency determining factors and uses thereof
0
...
Patent Primary Examiner
‌
Marcia S Noble
0
Patent abstract

The invention provides methods for reprogramming somatic cells to generate multipotent or pluripotent cells. Such methods are useful for a variety of purposes, including treating or preventing a medical condition in an individual. The invention further provides methods for identifying an agent that reprograms somatic cells to a less differentiated state.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11987815 Methods for reprogramming somatic cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.